Next-generation Sequencing in SARS-CoV-2 Research

Logo
Presented by

Jason Liu, PhD, Field Application Scientist at Roche Sequencing and Life Science

About this talk

In this webinar, we provide an overview of how NGS technologies are advancing our understanding of the SARS-CoV-2 virus and the COVID-19 pandemic. We review: - The structure and genomic organization of the SARS-CoV-2 virion - The roles of NGS in the fight against the COVID-19 pandemic, including understanding immune responses to infection - An overview of several NGS methods used in SARS-CoV-2 sequencing - How KAPA Library Preparation Kits for NGS are being used to answer questions about SARS-CoV-2 and COVID-19 MC-US-08879

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (17)
Subscribers (278)
Next-generation sequencing (NGS) is driving advances in translational and clinical research. From expanding our understanding of cancer, reproductive and developmental biology to unravelling complex microbial populations, NGS is touching all facets of human disease and well­being. Sample prep for NGS holds the key to unlocking the potential of every sample. Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple, and complete.